Üyelik Başvurusu   Şifremi Unuttum

Ana Sayfa  English  İletişim  
Dernek Görüşleri
       [ ]
Dokümanların tamamına ulaşmak için tıklayınız.


11 Kasım 2016

Çocuklardaki Randomize klinik çalışmalar yayınlanmıyor.. SocialDoctors İçerisinde Paylaş

 2016 Sep;138(3). pii: e20160223. doi: 10.1542/peds.2016-0223. Epub 2016 Aug 4.

Discontinuation and Nonpublication of Randomized Clinical Trials Conducted in Children.



Trial discontinuation and nonpublication represent potential waste in research resources and lead to compromises in medical evidence. Pediatric trials may be particularly vulnerable to these outcomes given the challenges encountered in conducting trialsin children. We aimed to determine the prevalence of discontinuation and nonpublication of randomized clinical trials (RCTs) conductedin pediatric populations.


Retrospective, cross-sectional study of pediatric RCTs registered in ClinicalTrials.gov from 2008 to 2010. Data were collected from the registry and associated publications identified (final search on September 1, 2015).


Of 559 trials, 104 (19%) were discontinued early, accounting for an estimated 8369 pediatric participants. Difficulty with patient accrual (37%) was the most commonly cited reason for discontinuationTrials were less likely to be discontinued if they were funded by industry compared with academic institutions (odds ratio [OR] 0.46, 95% confidence interval [CI] 0.27-0.77). Of the 455 completed trials, 136 (30%) were not published, representing 69 165 pediatric participants. Forty-two unpublished trials posted results on ClinicalTrials.gov. Trials funded by industry were more than twice as likely to result in nonpublication at 24 and 36 months (OR 2.21, 95% CI 1.35-3.64; OR 3.12, 95% CI 1.6-6.08, respectively) and had a longer mean time to publication compared with trials sponsored by academia (33 vs 24 months, P < .001).


In this sample of pediatric RCTs, discontinuation and nonpublication were common, with thousands of children exposed to interventions that did not lead to informative or published findings. Trial funding source was an important determinant of these outcomes, with both academic and industry sponsors contributing to inefficiencies.

« Geri

Klinik Araştırmalar Derneği © 2006-2007 PLEKSUS